ArticleRevista peruana de medicina experimental y salud publica2026
Adherence to antihypertensive treatment in patients at a tertiary hospital in Lima, Peru.
Article in Revista peruana de medicina experimental y salud publica, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In Peru, there are few reports on pharmacological adherence in patients with arterial hypertension. In this context, the present study aimed to determine adherence to antihypertensive treatment in patients treated at a tertiary-level social security hospital in Lima. A cross-sectional study was conducted in 250 hospitalized patients, over 18 years of age, with a diagnosis of primary arterial hypertension on pharmacological treatment. Adherence was evaluated using the Morisky questionnaire (MMAS-8), and variables such as prescribed medication, age, sex, marital status, and educational level were collected. 56.4% of the participants were male and 86.4% were over 60 years old. It was observed that 42% presented low pharmacological adherence and 58% medium adherence, with no cases of high adherence recorded. Monotherapy was the most frequent regimen (48%), with losartan, nifedipine, and enalapril being the most prescribed drugs. Finally, significant differences were identified between adherence to antihypertensive treatment and educational level and the number of drugs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.